Literature DB >> 18563947

Does direct-to-consumer advertising of antidepressants lead to a net social benefit?

Jon Jureidini1, Barbara Mintzes, Melissa Raven.   

Abstract

Mesh:

Substances:

Year:  2008        PMID: 18563947     DOI: 10.2165/00019053-200826070-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN: 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  38 in total

1.  Antidepressant drug use & the risk of suicide.

Authors:  David Healy; Graham Aldred
Journal:  Int Rev Psychiatry       Date:  2005-06

Review 2.  Pharmacoeconomic evaluation of antidepressants : a critical appraisal of methods.

Authors:  Sheikh Usman Iqbal; Mark Prashker
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

3.  Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study.

Authors:  Carlos Martinez; Stephan Rietbrock; Lesley Wise; Deborah Ashby; Jonathan Chick; Jane Moseley; Stephen Evans; David Gunnell
Journal:  BMJ       Date:  2005-02-19

4.  National Ambulatory Medical Care Survey: 2000 summary.

Authors:  Donald K Cherry; David A Woodwell
Journal:  Adv Data       Date:  2002-06-05

5.  Influence of patients' requests for direct-to-consumer advertised antidepressants: a randomized controlled trial.

Authors:  Richard L Kravitz; Ronald M Epstein; Mitchell D Feldman; Carol E Franz; Rahman Azari; Michael S Wilkes; Ladson Hinton; Peter Franks
Journal:  JAMA       Date:  2005-04-27       Impact factor: 56.272

6.  Discontinuation syndrome in dysthymic patients treated with selective serotonin reuptake inhibitors: a clinical investigation.

Authors:  Filippo Bogetto; Silvio Bellino; Raffaele Bonatto Revello; Luca Patria
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

Review 7.  Drugs versus placebo for dysthymia.

Authors:  M S Lima; J Moncrieff
Journal:  Cochrane Database Syst Rev       Date:  2000

8.  Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs.

Authors:  Elaine H Morrato; Anne M Libby; Heather D Orton; Frank V Degruy; David A Brent; Richard Allen; Robert J Valuck
Journal:  Am J Psychiatry       Date:  2007-11-06       Impact factor: 18.112

9.  Selective publication of antidepressant trials and its influence on apparent efficacy.

Authors:  Erick H Turner; Annette M Matthews; Eftihia Linardatos; Robert A Tell; Robert Rosenthal
Journal:  N Engl J Med       Date:  2008-01-17       Impact factor: 91.245

Review 10.  SSRIs and upper gastrointestinal bleeding: what is known and how should it influence prescribing?

Authors:  Susanne O Dalton; Henrik T Sørensen; Christoffer Johansen
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

View more
  3 in total

Review 1.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

2.  Public attitudes towards psychiatric medication: a comparison between United States and Germany.

Authors:  Georg Schomerus; Herbert Matschinger; Sebastian E Baumeister; Ramin Mojtabai; Matthias C Angermeyer
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

3.  Medicines Information and the Regulation of the Promotion of Pharmaceuticals.

Authors:  Teresa Leonardo Alves; Joel Lexchin; Barbara Mintzes
Journal:  Sci Eng Ethics       Date:  2018-05-02       Impact factor: 3.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.